Results 131 to 140 of about 2,705 (182)

Examining epidemiological models and economic analyses of typhoid conjugate vaccine: A scoping review. [PDF]

PLOS Glob Public Health
Mandaliya P, Orangi S, Kazungu J, Waithaka D, Kairu A, Bationo A, Masiye F, Onwujekwe O, Barasa E.   +8 more
europepmc   +1 more source

From Crisis to Control: A Study of Typhoid Conjugate Vaccine Efficacy in Harare, Zimbabwe (2017-2024). [PDF]

Open Forum Infect Dis
Bvochora T, Manyara J, Thilliez G, Vere M, Mukeredzi I, Nhamo D, Chitiyo F, Muzondo A, Juru A, Chonzi P, Phiri I, Smith AM, Chaibva BV, Mapingure M, Fuller W, Shrestha P, Nair P, Kingsley RA, Laxminarayan R, Musuka G, Mashe T.   +20 more
europepmc   +1 more source

Correction: Impact of the COVID-19 pandemic and typhoid conjugate vaccine introduction on typhoid fever in Nepal. [PDF]

PLoS Negl Trop Dis
Tamrakar D, Naga SR, Jung E, Shrestha B, Bista Roka P, Pokharel R, Shahi SB, Bajracharya AT, Mahadup SK, Katuwal N, Doyle K, Seidman JC, Carter AS, Luby SP, Bogoch II, Aiemjoy K, Garrett DO, Shrestha R, Andrews JR.   +18 more
europepmc   +1 more source

Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward. [PDF]

Open Forum Infect Dis, 2023
Russell AL, Hampton LM, Sinha A, Luquero FJ, Abdelwahab J.   +4 more
europepmc   +1 more source

Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso. [PDF]

J Pediatric Infect Dis Soc, 2023
Ouedraogo A, Diarra A, Nébié I, Barry N, Kabore JM, Tiono AB, Datta S, Liang Y, Mayo I, Oshinsky JJ, Tracy JK, Girmay T, Pasetti MF, Jamka LP, Neuzil KM, Sirima SB, Laurens MB.   +16 more
europepmc   +1 more source

Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India. [PDF]

PLOS Glob Public Health, 2023
Song D, Pallas SW, Shimpi R, Ramaswamy N, Haldar P, Harvey P, Bhatnagar P, Katkar A, Jayaprasad N, Kunwar A, Bahl S, Morgan W, Hutubessy R, Date K, Mogasale V.   +14 more
europepmc   +1 more source

Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities. [PDF]

Vaccine
Carter AS, Steele D, John J, Saha S, Laurens MB, Minta AA, Volavola L, Moedjito I, Phounphenghack K, Mahat D, Nyein SL, Gautam A, Sespeñe MFVS, Pati T, Huong NTT, Gupta N, George LS, Jayaprakasam M, Gupta A, Garrett DO.   +19 more
europepmc   +1 more source

Coverage survey of typhoid conjugate vaccine among children aged 6 months to 15 years in an urban slum settlement of Lyari Town Karachi, Pakistan. [PDF]

PLoS One, 2023
Batool R, Qureshi S, Haq Z, Yousafzai MT, Salam RA, Ali R, Sadaf T, Ali M, Qamar FN.   +8 more
europepmc   +1 more source

Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience. [PDF]

Hum Vaccin Immunother
Vadrevu KM, Chiteti SR, Dugyala R, Aileni VK, Kunta A, Patnaik BN, Ella R.   +6 more
europepmc   +1 more source

Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children. [PDF]

EClinicalMedicine
Nampota-Nkomba N, Nyirenda OM, Datta S, Mapemba V, Patel PD, Misiri T, Mwakiseghile F, Ndaferankhande JM, Lipenga B, Oshinsky J, Pasetti MF, Jamka LP, Gordon MA, Laurens MB, Neuzil KM, TyVAC team.   +15 more
europepmc   +1 more source